At a glance
ClinicalIndex Comparison RecordPhase 1Recruiting· 30 target
Drug / intervention
Washed Microbiota Transplantationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Washed Microbiota Transplantation for Tourette's Syndrome
The Second Hospital of Nanjing Medical University·interventional·Posted Dec 5, 2018·Updated Aug 19, 2024
In Brief
A Phase 1 clinical trial evaluating Washed Microbiota Transplantation for Tourette Syndrome. Currently recruiting, targeting 30 participants across 2 sites.
Detailed Summary
This study aimed to evaluate the efficacy of washed microbiota transplantation in the treatment of Tourette's syndrome (TS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTourette Syndrome
CountriesChina
CollaboratorsNanjing Medical University
Timeline
Phase 1Recruiting
2019202020212022202320242025202620272028
First PostedDec 2018
Enrollment StartApr 2024
TodayJul 2026
Primary CompletionOct 2027
First PostedDec 5, 2018
Enrollment StartApr 17, 2024
Primary CompletionOct 31, 2027
TodayJul 1, 2026
Enrollment to primary: 3.5 yearsPosted 7.6 years agoPrimary completion in 1.3 years
Interventions
Washed Microbiota Transplantationdrug
The prepared microbiota suspension was infused into the participates' lower gut.